Strategies for identifying modifier genes in cystic fibrosis

Michael P. Boyle

Research output: Contribution to journalArticle

Abstract

Even in patients with cystic fibrosis (CF) with identical CFTR genotypes, there is a wide range in the severity of lung disease, with some individuals facing death or lung transplantation early in life and others demonstrating mild lung disease well into adulthood. Although numerous environmental factors have been identified that influence CF pulmonary phenotype, there is now growing evidence that polymorphic variants in genes besides CFTR play an important role in determining severity of CF lung disease. This article reviews the most recent findings regarding genetic modifiers in CF and also discusses in detail the strategies currently being used to identify novel modifiers of CF pulmonary phenotype. These include single- and multicenter studies, twin and sib studies, microarray approaches, and whole genome association studies.

Original languageEnglish (US)
Pages (from-to)52-57
Number of pages6
JournalProceedings of the American Thoracic Society
Volume4
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Modifier Genes
Cystic Fibrosis
Lung Diseases
Phenotype
Twin Studies
Lung Transplantation
Genome-Wide Association Study
Multicenter Studies
Genotype
Genes

Keywords

  • Cystic fibrosis
  • Genotype
  • Modifier
  • Phenotype
  • Transforming growth factor β

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Physiology
  • Cell Biology

Cite this

Strategies for identifying modifier genes in cystic fibrosis. / Boyle, Michael P.

In: Proceedings of the American Thoracic Society, Vol. 4, No. 1, 01.2007, p. 52-57.

Research output: Contribution to journalArticle

@article{49a925104d8840c7a41eeb35dcb6dfbc,
title = "Strategies for identifying modifier genes in cystic fibrosis",
abstract = "Even in patients with cystic fibrosis (CF) with identical CFTR genotypes, there is a wide range in the severity of lung disease, with some individuals facing death or lung transplantation early in life and others demonstrating mild lung disease well into adulthood. Although numerous environmental factors have been identified that influence CF pulmonary phenotype, there is now growing evidence that polymorphic variants in genes besides CFTR play an important role in determining severity of CF lung disease. This article reviews the most recent findings regarding genetic modifiers in CF and also discusses in detail the strategies currently being used to identify novel modifiers of CF pulmonary phenotype. These include single- and multicenter studies, twin and sib studies, microarray approaches, and whole genome association studies.",
keywords = "Cystic fibrosis, Genotype, Modifier, Phenotype, Transforming growth factor β",
author = "Boyle, {Michael P.}",
year = "2007",
month = "1",
doi = "10.1513/pats.200605-129JG",
language = "English (US)",
volume = "4",
pages = "52--57",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - Strategies for identifying modifier genes in cystic fibrosis

AU - Boyle, Michael P.

PY - 2007/1

Y1 - 2007/1

N2 - Even in patients with cystic fibrosis (CF) with identical CFTR genotypes, there is a wide range in the severity of lung disease, with some individuals facing death or lung transplantation early in life and others demonstrating mild lung disease well into adulthood. Although numerous environmental factors have been identified that influence CF pulmonary phenotype, there is now growing evidence that polymorphic variants in genes besides CFTR play an important role in determining severity of CF lung disease. This article reviews the most recent findings regarding genetic modifiers in CF and also discusses in detail the strategies currently being used to identify novel modifiers of CF pulmonary phenotype. These include single- and multicenter studies, twin and sib studies, microarray approaches, and whole genome association studies.

AB - Even in patients with cystic fibrosis (CF) with identical CFTR genotypes, there is a wide range in the severity of lung disease, with some individuals facing death or lung transplantation early in life and others demonstrating mild lung disease well into adulthood. Although numerous environmental factors have been identified that influence CF pulmonary phenotype, there is now growing evidence that polymorphic variants in genes besides CFTR play an important role in determining severity of CF lung disease. This article reviews the most recent findings regarding genetic modifiers in CF and also discusses in detail the strategies currently being used to identify novel modifiers of CF pulmonary phenotype. These include single- and multicenter studies, twin and sib studies, microarray approaches, and whole genome association studies.

KW - Cystic fibrosis

KW - Genotype

KW - Modifier

KW - Phenotype

KW - Transforming growth factor β

UR - http://www.scopus.com/inward/record.url?scp=33846051977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846051977&partnerID=8YFLogxK

U2 - 10.1513/pats.200605-129JG

DO - 10.1513/pats.200605-129JG

M3 - Article

C2 - 17202292

AN - SCOPUS:33846051977

VL - 4

SP - 52

EP - 57

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 1

ER -